IL-22 could inhibit epidermal differentiation and promote inflammation in AD skin lesions by inducing the secretion of IL-6, and downregulate the expression of keratinocyte fibril aggregation proteins in keratinocytes, especially, to increase the degree of epidermal damage (168), which is closely related to the severity of AD. Here, IL6 is linked to Alzheimer disease.